Shareholder Information

Top 10 Largest Shareholders

(As of March 31,2024)

Name of shareholder Number of shares held（thousands) Percentage of shares held（％）
Master Trust Bank of Japan, Ltd. (Trust Account) 3,050 10.76
Takeda Pharmaceutical Company Limited 2,204 7.78
Zeria Pharmaceutical Co., Ltd.
 1,877 6.62
Custody Bank of Japan, Ltd. (Trust Account) 1,478 5.22
NIPPON ACTIVE VALUE FUND PLC
1,268 4.47
MUFG Bank, Ltd.
 1,100 3.88
Takashi Yamaguchi
 799 2.82
Kabushiki Kaisha YAMAGUCHI
 579 2.04
Nippon Life Insurance Company 522 1.84
The Toa Reinsurance Company, Limited
 500 1.76
Note 
  • The Company holds 2,231,957 shares as treasury shares, which are not included in the list of major shareholders.
  • Shareholding ratio is based on the number of shares exclusive of treasury shares (2,231,957 shares).

Status of Shares

Distribution of Shareholders

Share Unit Distribution

Number Of Shareholders

Highest/Lowest Share Price

Capital and Issued Shares

　　
Capital Issued shares
April 1, 2021 ¥1,197.9 million 30,563,199 shares
March 31, 2022 ¥1,197.9 million 30,563,199 shares
March 31, 2023 ¥1,197.9 million 30,563,199 shares
March 31, 2024 ¥1,197.9 million 30,563,199 shares

Notes: In April 2021, through a sole-share transfer, the Company was established as the wholly owned parent company of ASKA Pharmaceutical Co. Ltd.